首页 | 本学科首页   官方微博 | 高级检索  
检索        

腺病毒介导的RNA干扰ERCC1基因表达对逆转卵巢癌顺铂耐药的效果
引用本文:田丽娜,徐福强,姬力群,刘小平,单育,杨菲菲,陈静,瞿全新.腺病毒介导的RNA干扰ERCC1基因表达对逆转卵巢癌顺铂耐药的效果[J].武警医学,2019,30(7):591-595.
作者姓名:田丽娜  徐福强  姬力群  刘小平  单育  杨菲菲  陈静  瞿全新
作者单位:1.100043,北京市石景山医院妇产科;2.062550 青岛,中国科学院大学附属华北医院产科;3.300001,天津市第一中心医院妇产科
摘    要: 目的 探讨腺病毒介导的RNA干扰ERCC1基因表达逆转卵巢癌顺铂耐药的效果。方法 采用直接感染法、台盼蓝活细胞计数、MTT、Hoechst染色法及流式细胞仪检测等方法,绘制顺铂耐药卵巢癌细胞株SKOV3/DDP细胞生长曲线及倍增时间,检测SKOV3/DDP细胞感染重组病毒前后其顺铂的IC50值、细胞凋亡形态及细胞各周期的分布。结果 (1)顺铂浓度与SKOV3/DDP细胞抑制率呈线性正相关,相关系数r=0.9862(P<0.05),顺铂IC50为(13.93±0.37)μg/ml,耐药指数为1.79。(2)重组腺病毒感染后干扰ERCC1基因表达,SKOV3/DDP细胞对顺铂的敏感性分别增加了11.1%、16.7%、26.4%、33.5%,呈剂量依懒性(r=0.9716,P<0.05),耐药指数降至1.19。(3)重组腺病毒联合顺铂作用后,SKOV3/DDP细胞株G1期细胞比例增大,S期细胞比例增大,细胞凋亡率增高(P<0.05)。结论 干扰ERCC1基因表达可以通过诱导耐药肿瘤细胞SKOV3/DDP凋亡、调节细胞周期分布等途径逆转卵巢癌细胞的顺铂耐药。

关 键 词:卵巢癌    ERCC1基因  RNA干扰  顺铂  重组腺病毒表达载体  
收稿时间:2018-10-20

Reversal of cisplatin resistance in ovarian cancer by adenovirus-mediated RNA interference with ERCC1 gene expression in vitro
SHI Shan,ZHANG Lei,LIU Fengmei,LI Baozhi,YANG Xuedong.Reversal of cisplatin resistance in ovarian cancer by adenovirus-mediated RNA interference with ERCC1 gene expression in vitro[J].Medical Journal of the Chinese People's Armed Police Forces,2019,30(7):591-595.
Authors:SHI Shan  ZHANG Lei  LIU Fengmei  LI Baozhi  YANG Xuedong
Institution:1.Department of Obstetrics and Gynecology, Beijing Shijingshan Hospital, Beijing 100043, China;2. Department of Obstetrics, North China Hospital Affiliated to the University of Chinese Academy of Sciences,Qingdao 062550, China;3.Department of Obstetrics and Gynecology, Tianjin First Central Hospital, Tianjin 300001, China
Abstract:Objective To investigate the effect of cisplatin resistance being reversed in ovarian cancer by adenovirus-mediated RNA interference with ERCC1 gene expression.Methods The cisplatin-resistant SKOV3/DDP cells were directly infected with the recombinant adenovirus, and trypan blue counting, MTT, Hoechst staining and flow cytometry were used in this study. The growth curve, doubling time, IC50 value, apoptotic morphology and cell cycle scores of SKOV3/DDP cells before and after infection were detected.Results (1) The inhibition rate of SKOV3/DDP cells was positively correlated with the concentration of cisplatin. The correlation coefficient r=0.9862 (P<0.05). The IC50 value of cisplatin was (13.93±0.37)μg/ml, and the resistance index was 1.79. (2) The sensitivity of SKOV3/DDP cells to cisplatin increased by 11.1%, 16.7%, 26.4% and 33.5% respectively in a dose-dependent manner (r=0.9716, P<0.05) after being infected with the recombinant adenovirus, and the drug resistance index decreased to 1.19. (3) The proportion of G1 phase cells, S phase cells and apoptotic rate of SKOV3/DDP cells increased (P<0.05) after being infected with the recombinant adenovirus combined with cisplatin.Conclusions Interference with ERCC1 gene expressions can reverse cisplatin resistance in cisplatin-resistant ovarian cancer cell line SKOV3/DDP cells by inducing apoptosis and regulating cell cycle distribution.
Keywords:ovarian carcinoma  ERCC1 gene  RNA interference  cisplatin  recombinant adenovirus expression vector  
点击此处可从《武警医学》浏览原始摘要信息
点击此处可从《武警医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号